Benchmarking • Design learning • Functional differentiation
Established PFAC resources provide strong guidance. This APE integrates them into a local leadership workflow.
This comparison examines authoritative federal, professional, and peer-reviewed resources. The APE does not replace those resources. Its distinctive value is the integration of evidence, CMS Patient Safety Structural Measure Domain 5 traceability, local population context, closed-loop action, measurement, and competency traceability in one applied product.
Functional differentiation
What each resource is designed to do.
| Resource | Primary strength | What this APE adds for applied use |
|---|---|---|
| AHRQ Guide to Patient and Family Engagement | Tested hospital implementation guidance, including working with patients and families as advisors, communication, bedside shift report, and discharge planning. | Domain 5 traceability, local population analysis, evidence limitations, leadership ownership, and a closed-loop action tracker. |
| AHRQ CMS Patient Safety Structural Measure Domain resources | Federal resource mapping across the five structural-measure domains, including patient and family engagement. | A practical bridge from Domain 5 requirements to local evidence, gaps, accountable roles, and next actions. |
| Institute for Patient- and Family-Centered Care Reflecting Our Community Toolkit | PFAC representation, equitable recruitment, welcoming environments, health-equity partnership, and sustainability. | Connects representation and access findings to Upper Valley population context, governance decisions, measurement, and implementation follow-through. |
| Peer-reviewed PFAC literature | Defines what is known, what remains uncertain, and operational factors associated with stronger PFAC functioning. | Separates structure, process, implementation, experience, and outcome measures so unsupported causal claims are not embedded in the toolkit. |
| Dartmouth MPH APE and competency framework | Requires applied public-health work that translates academic skills into a field-setting product and demonstrates selected competencies. | Maps competencies directly to visible artifacts, calculations, evidence appraisal, leadership tools, and practice interpretation. |
Why this is more usable as an APE asset
Integration is the functional advantage.
Evidence and limitations stay attached to action.
The evidence summary and matrix distinguish research evidence, implementation guidance, public Dartmouth Health evidence, local descriptive analysis, and lived experience. This makes it possible to see what supports a decision and what remains unvalidated.
Population data changes the engagement design.
The applied analysis uses municipality-level population, poverty, disability, and age data plus access and navigation signals to inform representation and implementation planning rather than leaving the toolkit generic.
Patient input is connected to ownership and report-back.
The leadership tools capture what was raised, leadership disposition, accountable owner, due date, implementation status, evidence of change, and report-back.
Contribution is measured before impact is claimed.
The toolkit separates operational and implementation measures from downstream outcomes, consistent with the literature showing heterogeneous measurement and limited causal evidence for PFAC-attributable outcomes.
Domain 5 becomes traceable work.
CMS Patient Safety Structural Measure Domain 5 is translated into evidence-state review, accountable roles, gaps, and actions rather than presented only as a reference document.
Competency proof is visible.
The deliverables page explicitly connects selected Dartmouth and CEPH competencies to the artifact, calculation, or management tool that demonstrates each competency.
Claim boundary
Functionally stronger does not mean clinically proven superior.
The defensible claim is that this APE combines functions that are usually distributed across separate guidance documents, evidence reviews, local data files, and implementation tools. That is an applied usability and traceability advantage, not a clinical effectiveness claim. The site does not claim that PFAC activity by itself improves safety, experience, or clinical outcomes.
Can leaders trace each recommendation back to its evidence type and limitation?
Can local population context change who should be represented and how participation barriers are addressed?
Can leaders document what patients and families raised, who owns the response, and whether the loop was closed?
Can the same artifact demonstrate public-health analysis, leadership, interprofessional integration, and engagement competencies?
Validation sources
Authoritative and peer-reviewed comparison base.
- Agency for Healthcare Research and Quality. Guide to Patient and Family Engagement in Hospital Quality and Safety. AHRQ. Content reviewed March 2023.
- Agency for Healthcare Research and Quality. Resources by the CMS Patient Safety Structural Measure Domains. AHRQ. Content reviewed April 2025.
- Institute for Patient- and Family-Centered Care. Reflecting Our Community: A Toolkit to Strengthen Patient and Family Advisory Councils. Accessed September 8, 2026.
- Lewis B, Cochran C, Marquez E, et al. Use of hospital patient and family advisory councils: a scoping study. J Patient Exp. 2025;12:23743735251316995. doi:10.1177/23743735251316995. PMID:39931354; PMCID:PMC11808756.
- Lewis B, Cochran C, Shoemaker S, et al. Hospital patient and family advisory councils: a quantitative study on how councils are used and predictors of effective councils. J Patient Exp. 2026;13:23743735261415786. doi:10.1177/23743735261415786
- Rramani Dervishi Q, Blum Y, Brust L, Weigl M. Engaging patient and family advisory councils (PFACs) in patient safety in healthcare organisations: a rapid scoping review. BMJ Open Qual. 2026;15(1):e004040. doi:10.1136/bmjoq-2025-004040
- Dartmouth Health Sciences. Practicum Experience and MPH Competencies. Accessed September 8, 2026.